glp 1 agonist trials Clinical Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled | Drugs GLP-1 receptor agonists | How

Lupus, Sjgrens, and Ankylosing Spondylitis and More GLP-1s may calm immune responses, offset steroid-induced weight gain, protect the kidneys, and lower heart disease risk

doi: 10.1007/s40263-016-0361-4

Expert anesthesiologist provides guidance for perioperative care of patients on GLP-1RA therapy

These results far exceed the modest weight changes typically seen with lifestyle intervention alone

33 A retrospective analysis of 164 patients with T2D who switched to OW semaglutide from either liraglutide or dulaglutide (REALiSeDM), having been on the initial GLP1RA for at least 3 months, also showed a reduction in HbA 1c following the switch

PKA directly phosphorylates sulfonylurea receptor 1 (SUR1), a regulatory subunit of voltage-dependent K + channels and KATP channels, increasing membrane depolarization and voltage-gated Ca 2+ channel activation